Roberto Diletti

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score

Fourth Universal Definition of Myocardial Infarction (2018)

Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review

Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease

The changing landscape of atherosclerosis

The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Clinical effects of Helicobacter pylori outside the stomach

Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?

Atherosclerosis

New concepts in the design of drug-eluting coronary stents

The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Pretreatment With P2Y ₁₂ Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified

Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease

Does body mass index truly affect mortality and cardiovascular outcomes in patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft? A systematic review and network meta‐analysis

Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Biochemical changes during experimental carcinogenesis. II. Glutamine and glutamic acid metabolism in perfused livers of azo dye-fed rats.

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Biodegradable metals

Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real‐world results from the East Denmark Heart Registry

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Fourth Universal Definition of Myocardial Infarction (2018)

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Iron-Deficiency Anemia

Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis

Fourth universal definition of myocardial infarction (2018)

Metabolism of glutamine and glutamate by rat liver mitochondria

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents

The Effect of Static and Dynamic Loading on Degradation of PLLA Stent Fibers

Complete Revascularization Is Not a Prerequisite for Success in Current Transcatheter Aortic Valve Implantation Practice

Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds

Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score

Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

NIRS and IVUS for Characterization of Atherosclerosis in Patients Undergoing Coronary Angiography

1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Progress in Treatment by Percutaneous Coronary Intervention: The Stent of the Future

Early detection and invasive passivation of future culprit lesions: A future potential or an unrealistic pursuit of Chimeras?

Clinical and Angiographic Characteristics of Patients Likely to Have Vulnerable Plaques

Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography

ABSORB II randomized controlled trial

Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study

Impact of body mass index on long‐term clinical outcomes after second‐generation drug eluting stent implantation: Insights from the international global RESOLUTE program

Angiographic and Optical Coherence Tomography Insights Into Bioresorbable Scaffold Thrombosis